Nóra Sipeki MD, PhD
Nóra Sipeki MD, PhD
University of Debrecen; Department of Internal Medicine, Division of Gastroenterology
Verified email at
Cited by
Cited by
Immune dysfunction in cirrhosis
N Sipeki, P Antal-Szalmas, PL Lakatos, M Papp
World journal of gastroenterology: WJG 20 (10), 2564, 2014
Rediscovery of the anti-pancreatic antibodies and evaluation of their prognostic value in a prospective clinical cohort of Crohn’s patients: the importance of specific target …
M Papp, N Sipeki, T Tornai, I Altorjay, GL Norman, Z Shums, ...
Journal of Crohn's and Colitis 9 (8), 659-668, 2015
High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis
M Papp, N Sipeki, Z Vitalis, T Tornai, I Altorjay, I Tornai, M Udvardy, ...
Journal of hepatology 59 (3), 457-466, 2013
Rapid response to treatment of autoimmune hepatitis associated with remission at 6 and 12 months
S Pape, TJG Gevers, JM Vrolijk, B van Hoek, G Bouma, ...
Clinical gastroenterology and hepatology 18 (7), 1609-1617. e4, 2020
Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients
G Kovacs, N Sipeki, B Suga, T Tornai, K Fechner, GL Norman, Z Shums, ...
PLoS One 13 (3), e0194166, 2018
Macrophage activation marker, soluble CD 163, is an independent predictor of short‐term mortality in patients with cirrhosis and bacterial infection
T Tornai, Z Vitalis, N Sipeki, T Dinya, D Tornai, P Antal‐Szalmas, ...
Liver International 36 (11), 1628-1638, 2016
Identification of chitinase-3-like protein 1 as a novel neutrophil antigenic target in Crohn’s disease
C Deutschmann, M Sowa, J Murugaiyan, U Roesler, N Röber, K Conrad, ...
Journal of Crohn's and Colitis 13 (7), 894-904, 2019
Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn’s disease
N Sipeki, L Davida, E Palyu, I Altorjay, J Harsfalvi, PA Szalmas, Z Szabo, ...
World journal of gastroenterology: WJG 21 (22), 6952, 2015
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis
T Tornai, D Tornai, N Sipeki, I Tornai, R Alsulaimani, K Fechner, ...
Scientific reports 8 (1), 399, 2018
Lectin‐complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections
I Foldi, T Tornai, D Tornai, N Sipeki, Z Vitalis, I Tornai, T Dinya, ...
Liver International 37 (7), 1023-1031, 2017
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
S Pape, TJG Gevers, JM Vrolijk, B van Hoek, G Bouma, ...
Liver international 40 (9), 2164-2171, 2020
Major changes of von Willebrand factor multimer distribution in cirrhotic patients with stable disease or acute decompensation
E Palyu, J Harsfalvi, T Tornai, M Papp, M Udvardy, K Szekeres-Csiki, ...
Thrombosis and Haemostasis 118 (08), 1397-1408, 2018
Risk matrix for prediction of disease progression in a referral cohort of patients with Crohn’s disease
PL Lakatos, N Sipeki, G Kovacs, E Palyu, GL Norman, Z Shums, ...
Journal of Crohn's and Colitis 9 (10), 891-898, 2015
Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study
D Tornai, P Antal-Szalmas, T Tornai, M Papp, I Tornai, N Sipeki, T Janka, ...
BMC gastroenterology 21, 1-13, 2021
Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality
D Tornai, Z Vitalis, A Jonas, T Janka, I Foldi, T Tornai, N Sipeki, A Csillag, ...
Clinics and Research in Hepatology and Gastroenterology 45 (5), 101579, 2021
Anti-neutrophil cytoplasmic antibody testing by indirect immunofluorescence: computer-aided versus conventional microscopic evaluation of routine diagnostic samples from …
G Nagy, I Csípő, T Tarr, G Szűcs, A Szántó, T Bubán, N Sipeki, ...
Clinica Chimica Acta 511, 117-124, 2020
P288 Gut barrier failure biomarkers in IBD: Is there anything new beyond „The Wall’?
N Sipeki, P Kovats, B Balogh, Z Shums, GL Norman, P Antal-Szalmas, ...
Journal of Crohn's and Colitis 14 (Supplement_1), S296-S296, 2020
Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn’s
U Roesler, N Röber, K Conrad, MW Laass, D Bogdanos, N Sipeki, ...
J Crohns Colitis 894, 904, 2019
P152 Reconsidering the prognostic value of traditional serologic antibodies in Crohn's disease–immunoglobulin classes to take the centre stage
N Sipeki, GL Norman, Z Shums, G Veres, PL Lakatos, P Antal-Szalmas, ...
Journal of Crohn's and Colitis 11 (suppl_1), S153-S154, 2017
Sa1156 Accelerated Treatment Strategy in Inflammatory Bowel Diseases; Is It Associated With a Change in the Disease Course?
PA Golovics, K Farkas, N Sipeki, Z Kurti, M Rutka, LS Kiss, BD Lovasz, ...
Gastroenterology 148 (4), S-242-S-243, 2015
The system can't perform the operation now. Try again later.
Articles 1–20